Medicinal cannabis is being made available under a pilot programme. The pilot programme which allows access to cannabis-based products for medical use has been launched by the Minister for Health, Simon Harris.
Legislation giving the go ahead for the Medical Cannabis Access Programme to operate in Ireland was signed yesterday by Simon Harris. Work on the establishment had began two years ago following examination by the Health Products Regulatory Authority (HPRA). It suggested that cannabis-based products be made available to some patients that suffer with multiple sclerosis and epilepsy, and people suffering nausea from undergoing chemotherapy.
At present, there are no medicinal cannabis products available in Ireland and this programme will operate on a pilot basis for five years. The legislation means that commercial operators whose cannabis products meet the specified requirements can now supply products to the Irish markets. This programme enables a medical consultant to prescribe a cannabis-based treatment in some cases where patients fail to respond to standard treatment.
If you would like to get in touch with MIAS Pharma, please email email@example.com or call us on +353 (1) 846 3605. To find out more about our services, click here.